Two Sigma Advisers LP Sells 214,100 Shares of Masimo Co. (NASDAQ:MASI)

Two Sigma Advisers LP cut its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 97.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,500 shares of the medical equipment provider's stock after selling 214,100 shares during the quarter. Two Sigma Advisers LP's holdings in Masimo were worth $744,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of MASI. Barclays PLC grew its stake in shares of Masimo by 152.6% in the third quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider's stock worth $5,329,000 after purchasing an additional 24,137 shares during the last quarter. Blue Trust Inc. lifted its holdings in Masimo by 56.3% in the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider's stock worth $33,000 after buying an additional 71 shares during the period. Greenleaf Trust purchased a new stake in Masimo in the fourth quarter worth about $208,000. Trust Point Inc. purchased a new stake in Masimo in the fourth quarter worth about $230,000. Finally, Calamos Advisors LLC purchased a new stake in Masimo in the fourth quarter worth about $2,691,000. 85.96% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have commented on MASI shares. Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Thursday, April 10th. Raymond James lowered their price objective on shares of Masimo from $204.00 to $185.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. Wells Fargo & Company lowered their target price on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a report on Wednesday, May 7th. Piper Sandler reiterated an "overweight" rating and set a $200.00 target price (down from $215.00) on shares of Masimo in a report on Wednesday, May 7th. Finally, Wall Street Zen lowered shares of Masimo from a "buy" rating to a "hold" rating in a report on Friday, May 30th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $191.60.

Insider Activity at Masimo

In other news, Director Craig B. Reynolds sold 2,053 shares of the firm's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total transaction of $341,064.89. Following the completion of the transaction, the director now owns 16,581 shares in the company, valued at $2,754,601.53. This trade represents a 11.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Bilal Muhsin sold 30,000 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the transaction, the chief operating officer now owns 24,172 shares of the company's stock, valued at approximately $4,048,568.28. The trade was a 55.38% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,053 shares of company stock worth $6,998,565. 9.70% of the stock is owned by corporate insiders.

Masimo Stock Up 2.2%

MASI stock traded up $3.55 during midday trading on Friday, hitting $168.27. The company's stock had a trading volume of 64,761 shares, compared to its average volume of 602,078. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo Co. has a 12 month low of $101.61 and a 12 month high of $194.88. The company has a market cap of $9.12 billion, a PE ratio of 116.05 and a beta of 1.19. The firm's 50-day moving average is $156.96 and its 200-day moving average is $167.24.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.12. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $372.00 million during the quarter, compared to the consensus estimate of $367.79 million. During the same quarter in the previous year, the firm posted $0.77 EPS. The company's revenue for the quarter was down 24.5% compared to the same quarter last year. On average, equities research analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.